Citigroup’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,316
| Closed | -$13.2K | – | 5012 |
|
|
2023
Q4 | $13.2K | Buy |
1,316
+470
| +56% | +$4.72K | ﹤0.01% | 4363 |
|
|
2023
Q3 | $2.44K | Sell |
846
-377
| -31% | -$1.09K | ﹤0.01% | 4161 |
|
|
2023
Q2 | $4.66K | Buy |
1,223
+463
| +61% | +$1.76K | ﹤0.01% | 4474 |
|
|
2023
Q1 | $1.41K | Sell |
760
-11
| -1% | -$20 | ﹤0.01% | 4405 |
|
|
2022
Q4 | $1.77K | Buy |
771
+53
| +7% | +$122 | ﹤0.01% | 4506 |
|
|
2022
Q3 | $2K | Sell |
718
-2,371
| -77% | -$6.6K | ﹤0.01% | 4752 |
|
|
2022
Q2 | $17K | Sell |
3,089
-366
| -11% | -$2.01K | ﹤0.01% | 4403 |
|
|
2022
Q1 | $8K | Sell |
3,455
-3,019
| -47% | -$6.99K | ﹤0.01% | 4855 |
|
|
2021
Q4 | $39K | Buy |
6,474
+5,496
| +562% | +$33.1K | ﹤0.01% | 4423 |
|
|
2021
Q3 | $14K | Sell |
978
-1,254
| -56% | -$18K | ﹤0.01% | 4633 |
|
|
2021
Q2 | $29K | Buy |
2,232
+1,232
| +123% | +$16K | ﹤0.01% | 4436 |
|
|
2021
Q1 | $15K | Buy |
+1,000
| New | +$15K | ﹤0.01% | 4752 |
|